Shopping Cart
- Remove All
- Your shopping cart is currently empty
Claudin-18.2 Protein-VLP, Mouse, Recombinant (His & Strep) is expressed in HEK293 Cells. The accession number is P56857-3.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μg | $773 | Backorder | |
100 μg | $1,620 | Backorder | |
500 μg | $5,730 | Backorder |
Biological Activity | Immobilized Recombinant Mouse Claudin-18.2 Protein (VLP, Full-Length, His & Strep Tag) at 5 μg/mL (100 μL/well) can bind Osemitamab, the EC50 is 3-15 ng/mL. |
Description | Claudin-18.2 Protein-VLP, Mouse, Recombinant (His & Strep) is expressed in HEK293 Cells. The accession number is P56857-3. |
Species | Mouse |
Expression System | HEK293 Cells |
Tag | N-His, C-Strep |
Accession Number | P56857-3 |
Synonyms | Cldn18 |
Construction | A DNA sequence encoding the Mouse CLDN18 (Full Length) (P56857-3) (Ser2-Val264) was expressed, with a polyhistidine tag at the N-terminus and a Strep tag at the C-terminus. |
Molecular Weight | 30.56 kDa (predicted) |
Endotoxin | < 1.0 EU per μg protein as determined by the LAL method. |
Formulation | Supplied as sterile 50 mM Hepes, 150 mM NaCl, 10% Trehalose, pH 7.2. Please contact us for any concerns or special requirements. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
Stability & Storage | Samples are stable for up to twelve months from date of receipt at -70℃. Store it under sterile conditions at -70℃ or lower. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
Shipping | It is supplied and shipped as liquid with dry ice. |
Research Background | Claudins family member Claudin18 (CLDN18) is a four-pass transmembrane protein with two extracellular loops and cytoplasmic N- and C-tails found in tight junctions. CLDN18 modulates paracellular permeability, polarity, and signaling. CLDN18 deficiency has been associated with atrophic gastritis, spasmolytic polypeptide-expressing metaplasia (SPEM), and asthma. Lung-specific CLDN18.1 modulates alveolar epithelial type II (AT2) cell proliferation and organ size. Restoration of CLDN18.1 expression in human lung cancer cells has been shown to suppress proliferation, inhibiting the IGF-1R/AKT axes. Not expressed in other healthy tissues, gastric mucosa-specific isoform CLDN18.2 expression manifests in primary gastric cancers. CLDN18.2 at the surface of epithelial tumor cells is a target in antibody and CAR-therapies currently in development. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.